Increased UDP-Glucuronosyltransferase Activity and Decreased Prostate Specific Antigen Production by Biochanin a in Prostate Cancer Cells Xiao-Ya Sun, Cathie A

Total Page:16

File Type:pdf, Size:1020Kb

Increased UDP-Glucuronosyltransferase Activity and Decreased Prostate Specific Antigen Production by Biochanin a in Prostate Cancer Cells Xiao-Ya Sun, Cathie A [CANCER RESEARCH 58. 2379-2384, June 1, 1998| Increased UDP-glucuronosyltransferase Activity and Decreased Prostate Specific Antigen Production by Biochanin A in Prostate Cancer Cells Xiao-Ya Sun, Cathie A. Plouzek, James P. Henry,1 Thomas T. Y. Wang, and James M. Phang2 Laboratory of Nutritional and Molecular Regulation, National Cancer Institute-Frederick Cancer Research and Development Center. NIH. Frederick. Maryland 21702-1201 ABSTRACT Because androgen levels in the prostate may be clinically impor tant, the modulation of UDPGT and androgen metabolism by dietary Our laboratory has characterized androgen metabolism in an andro- factors is of considerable interest. Various studies have shown that gen-responsive prostate cancer cell line (LNCaP) and showed that these consumption of soybean is associated with low incidence of prostate cells accumulated intracellular testosterone primarily as glucuronidated metabolites. Using a cell-free assay with testosterone as substrate, we cancer in Asian populations (6). Flavonoids, a family of compounds showed that LNCaP had UDP-glucuronosyltransferase (UDPGT) activity. plentiful in fruits and vegetables and especially in soy products, may Because dietary factors, such as flavonoids in soy products, may reduce reduce the risk for hormone-dependent cancers (7). We undertook the the risk for hormone-dependent cancers, we studied the effects of fla current studies to examine the possible effects of flavonoids on vonoids on testosterone-UDPGT activity. LNCaP cells were exposed to testosterone-UDPGT activity and on the metabolism of testosterone in selected flavonoids for up to 6 days. The increase in UDPGT-specific prostate cancer cells. We found that UDPGT was induced by fla activity was linear over this period. Of the compounds tested, biochanin A vonoids in LNCaP cells, and this increase in UDPGT not only affected was the most potent, with increased activity at concentration range 0.5-50 the conversion of testosterone to its conjugated glucuronide in intact JIM. Activities were linear for time and protein and were unaffected by LNCaP cells but also correlated with altered production of PSA, an flavonoids added directly to the assay. Kinetics studies showed no change androgen-responsive marker of prostate cancer (8). in A,,, for testosterone in the face of these large increases in specific activity. Cellular metabolism of testosterone reflected the increase in enzyme activity. Intact cells treated with biochanin A produced testoster- MATERIALS AND METHODS one-glucuronide from testosterone at twice the rate of controls. The steroid form of the UDPGT transcript was expressed in LNCaP cells and Chemicals. Radiolabeled ([^Hj-l^.o^Hestosterone was obtained from was enhanced in biochanin A-treated LNCaP cells. Additionally, bio New England Nuclear (Boston. MA). Unlabeled testosterone. UDP-glucuronic chanin A markedly decreased prostate specific antigen (PSA) level against acid, biochanin A. apigenin. kaempterol. quercetin. naringcnin, and HPLC the effect of testosterone on PSA production. Biochanin A significantly solvents were obtained from Sigma Chemical Co. (St. Louis, MO). Daid/ein. decreased the testosterone-stimulated release of PSA, presumably because genistein, galangin. tbrmononetin. and prunetin were purchased from Indorine biochanin A increased UDPGT and increased the intracellular glucu- Chemical Co. (Somerville. NJ). Fresh stock solutions of various flavonoid ronidation of testosterone. These studies suggest that the modulation of compounds were prepared in DMSO at a concentration of 50 mM before each hormone metabolism by dietary factors may be important in the preven experiment. tion and treatment of prostate cancer. LNCaP Cell Culture. The human prostatic carcinoma cell line LNCaP was obtained from the American Type Culture Collection (Rockville, MD). INTRODUCTION Cell culture components were purchased from Biofluids. Inc. (Rockville. MD). Cells were cultured (37°C.5% CO2) in RPMI 1640 supplemented with 10% It is well established that androgens (testosterone and its metabo FBS. penicillin ( 100 U/ml) and streptomycin 1100 fig/ml). Cells were passaged lites) play an important role in the normal growth and function of the every 6-7 days by trypsinization. and the culture medium was changed every prostate ( 1). Changes in androgen metabolism or responsiveness to 2-3 days. Cell Treatment for Enzyme Assay. LNCaP cells (1 X IO5)were plated in androgens have been implicated in the formation of benign prostatic 75-cm2 flasks in the presence of 25 ml of growth medium and allowed to attach hypertrophy and prostate cancer ( 1). The conjugation of steroid hormones with UDP-glucuronic acid is for 1 day. On the following day (day 1). each of the selected tlavonoid catalyzed by the enzyme UDPGT3 (EC 2.4.1.17; Ref. 2). This reac compounds at varying concentrations was added to the incubation medium. The final concentration of DMSO was 0.1 c/t in the medium. On day 3. medium tion, which converts steroids to more polar derivatives, not only was replaced with fresh medium containing same additives with or without inactivates but also expedites its elimination from tissues (3). Al flavonoids and maintained for an additional 3 days. though conjugation of steroid hormones occurs primarily in the liver, Preparation of Cell Homogenates for Enzyme Assay. Treated cells were it occurs also in peripheral tissues and may play a role in regulating harvested by scraping the cells into PBS. centrifuged. and resuspended in androgen levels in the prostate. Our laboratory (4) and others (5) have 1 ml of HBSS containing 25 mM HEPES buffer at pH 7.4 (9). The characterized testosterone metabolism in an androgen-responsive resuspended cells were disrupted by sonication. and the resultant homoge- nate was stored at -70°C. Protein concentrations for these homogenates prostate cancer cell line (LNCaP) and showed that these cells accu were determined by Lowry's method (10) using BCA Protein Assay Rea mulated intracellular testosterone primarily as glucuronidated deriv atives. Using a cell-free assay with testosterone as substrate, we gent (Pierce. Rockford, IL). UDPGT Assay. UDPGT activity was measured according to methods showed that LNCaP prostate cancer cells had testosterone-UDPGT described previously (4). The reaction mixture contained: 1 /iCi ['Hltestos- activity (4). terone. 4 /IM unlabeled testosterone. 5 mM UDP-glucuronic acid, and 100 /il of homogenate protein obtained from LNCaP cells in a final volume of 1 ml (HBSS containing 25 mM HEPES buffer). After l-h incubation at 37°C,the Received 11/25/97: accepted 4/2/98. The costs of publication of this article were defrayed in part by the payment of page mixture was acidified with 25 /xl of l N HCI for 15 min to release androgen charges. This article must therefore be hereby marked advertisement in accordance with steroids trapped by binding proteins (11). The samples were then neutralized 18 U.S.C. Section 1734 solely to indicate this fact. ' Present address: Gillette Research Institute. Gaithersburg, MD 20879. with 1 ml of PBS and 5 /il of 10 N NaOH. Metabolites first were separated on 2 To whom requests for reprints should be addressed, at National Cancer Institute. C,g columns (Waters. Milford, MA) and then were analyzed on the Waters Laboratory of Nutritional and Molecular Regulation. Building 560. Room 12-91. Fred HPLC system with a Supelcosil 5 mm LC-18 reverse phase column (Supelco. erick. MD 21702. 3 The abbreviations used are: UDPGT. UDP-glucuronosyltransferase; PSA. prostate- Inc., Bellefonte. PA) (12). An isocratic mobile phase consisting of mclhanol: specific antigen; HPLC. high-performance liquid chromatography: FBS. fetal bovine acetonitrile:water (15:45:40, v/v/v) for organic metabolites was used, whereas serum. 35% acetonitrile. 0.1% trifluroacetic acid in water at a flow rate of I ml/min 2379 Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 1998 American Association for Cancer Research. EFFECT OF BIOCHANIN A ON LNCaP CELLS was used to identify polar metabolites. The effluent was fed into a FLO-ONE/ RESULTS Beta online radioactive flow detector (Radiomatic. Meriden, CT). The testos terone and conjugated testosterone were separated and identified by comparing Stimulation of UDPGT Activity by Selected Flavonoids on the characteristic clution times with integrated standard peaks: testosterone and LNCaP Cells. Flavonoidsarea largeclass of naturalcompoundsthat testosterone glucuronide. Characterization of metabolites in the HPLC eluant are found in a wide variety of fruits and vegetables. The selected was also performed with a mass spectrometer as described by Henry et al. (4). flavonoids were apigenin, galangin, kaempferol, quercetin, narin- UDPGT activity was expressed as testosterone-glucuronide formation in pmol/ genin, and quercetin, whereas the tested isoflavones were biochanin h-/xg protein. A, daidzein, formononetin. genistein, and prunetin. Structures of the Cellular Metabolism of Testosterone. LNCaP cells (1 x IO5)were plated selected flavonoids were shown in Fig. 1. on day 0. and biochanin A (5 ¿tM)where indicated was added to the medium LNCaP cells were exposed to each of the selected flavonoids for 6 on day I. This medium was replaced with or without biochanin A on day 3. On days. All of the selected flavonoids stimulated the activity of testos- day 6 at the beginning of the experiment, growth medium was removed and terone-UDPGT. which conjugates testosterone to testosterone-glucu substituted with 2 ml of fresh medium without serum or biochanin A. After an ronide. Fig. 2 illustrates the relative effect on testosterone-UDPGT by hour of equilibration, cells were exposed to 2 ml of fresh medium containing [ !H[testosterone (92.1 Ci/mmol) and unlabcled testosterone so that the final selected flavonoids at a concentration of 5 JU.M.Themost effective concentration of testosterone was 31.2 nM. This concentration was chosen to compound was biochanin A (5 /AM),which stimulated UDPGT activ approximate the total plasma testosterone concentration of 20 nM (13). Cells ity about 10-fold. were incubated at 37°C.After incubation, aliquots of media were collected and Increase of UDPGT Activity by Biochanin A on LNCaP Cells.
Recommended publications
  • Pharmacokinetic Interactions Between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
    life Review Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance Laura Rombolà 1 , Damiana Scuteri 1,2 , Straface Marilisa 1, Chizuko Watanabe 3, Luigi Antonio Morrone 1, Giacinto Bagetta 1,2,* and Maria Tiziana Corasaniti 4 1 Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, University of Calabria, 87036 Rende, Italy; [email protected] (L.R.); [email protected] (D.S.); [email protected] (S.M.); [email protected] (L.A.M.) 2 Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy 3 Department of Physiology and Anatomy, Tohoku Pharmaceutical University, 981-8558 Sendai, Japan; [email protected] 4 School of Hospital Pharmacy, University “Magna Graecia” of Catanzaro and Department of Health Sciences, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0984-493462 Received: 28 May 2020; Accepted: 30 June 2020; Published: 4 July 2020 Abstract: The therapeutic efficacy of a drug or its unexpected unwanted side effects may depend on the concurrent use of a medicinal plant. In particular, constituents in the medicinal plant extracts may influence drug bioavailability, metabolism and half-life, leading to drug toxicity or failure to obtain a therapeutic response. This narrative review focuses on clinical studies improving knowledge on the ability of selected herbal medicines to influence the pharmacokinetics of co-administered drugs. Moreover, in vitro studies are useful to anticipate potential herbal medicine-drug interactions.
    [Show full text]
  • Nutraceuticals Brian Lockwood
    CjigVXZji^XVah HZXdcYZY^i^dc 7g^VcAdX`lddY 00 Prelim 2/3/07 18:51 Page i Nutraceuticals 00 Prelim 2/3/07 18:51 Page ii 00 Prelim 2/3/07 18:51 Page iii Nutraceuticals A guide for healthcare professionals Second edition Brian Lockwood BPharm, PhD, MRPharmS Senior Lecturer in Pharmacy, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK London • Chicago 00 Prelim 2/3/07 18:51 Page iv Published by the Pharmaceutical Press An imprint of RPS Publishing 1 Lambeth High Street, London SE1 7JN, UK 100 South Atkinson Road, Suite 200, Grayslake, IL 60030–7820, USA © Pharmaceutical Press 2007 is a trade mark of RPS Publishing RPS Publishing is the publishing organisation of the Royal Pharmaceutical Society of Great Britain First edition published 2002 Second edition published 2007 Typeset by Type Study, Scarborough, North Yorkshire Printed in Great Britain by TJ International, Padstow, Cornwall ISBN 978 0 85369 659 9 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or implied, with regard to the accuracy of the information contained in this book and cannot accept any legal responsibility or liability for any errors or omissions that may be made. The right of Brian Lockwood to be identified as the author of this work has been asserted by him in accordance with sections 77 and 78 and subject to section 79(6) of the Copyright, Designs and Patents Act, 1988.
    [Show full text]
  • Memorandum Date: June 6, 2014
    DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Memorandum Date: June 6, 2014 From: Bisphenol A (BPA) Joint Emerging Science Working Group Smita Baid Abraham, M.D. ∂, M. M. Cecilia Aguila, D.V.M. ⌂, Steven Anderson, Ph.D., M.P.P.€* , Jason Aungst, Ph.D.£*, John Bowyer, Ph.D. ∞, Ronald P Brown, M.S., D.A.B.T.¥, Karim A. Calis, Pharm.D., M.P.H. ∂, Luísa Camacho, Ph.D. ∞, Jamie Carpenter, Ph.D.¥, William H. Chong, M.D. ∂, Chrissy J Cochran, Ph.D.¥, Barry Delclos, Ph.D.∞, Daniel Doerge, Ph.D.∞, Dongyi (Tony) Du, M.D., Ph.D. ¥, Sherry Ferguson, Ph.D.∞, Jeffrey Fisher, Ph.D.∞, Suzanne Fitzpatrick, Ph.D. D.A.B.T. £, Qian Graves, Ph.D.£, Yan Gu, Ph.D.£, Ji Guo, Ph.D.¥, Deborah Hansen, Ph.D. ∞, Laura Hungerford, D.V.M., Ph.D.⌂, Nathan S Ivey, Ph.D. ¥, Abigail C Jacobs, Ph.D.∂, Elizabeth Katz, Ph.D. ¥, Hyon Kwon, Pharm.D. ∂, Ifthekar Mahmood, Ph.D. ∂, Leslie McKinney, Ph.D.∂, Robert Mitkus, Ph.D., D.A.B.T.€, Gregory Noonan, Ph.D. £, Allison O’Neill, M.A. ¥, Penelope Rice, Ph.D., D.A.B.T. £, Mary Shackelford, Ph.D. £, Evi Struble, Ph.D.€, Yelizaveta Torosyan, Ph.D. ¥, Beverly Wolpert, Ph.D.£, Hong Yang, Ph.D.€, Lisa B Yanoff, M.D.∂ *Co-Chair, € Center for Biologics Evaluation & Research, £ Center for Food Safety and Applied Nutrition, ∂ Center for Drug Evaluation and Research, ¥ Center for Devices and Radiological Health, ∞ National Center for Toxicological Research, ⌂ Center for Veterinary Medicine Subject: 2014 Updated Review of Literature and Data on Bisphenol A (CAS RN 80-05-7) To: FDA Chemical and Environmental Science Council (CESC) Office of the Commissioner Attn: Stephen M.
    [Show full text]
  • Steroid Profiling in Urine of Intact Glucuronidated and Sulfated
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Ghent University Academic Bibliography Journal of Chromatography A 1624 (2020) 461231 Contents lists available at ScienceDirect Journal of Chromatography A journal homepage: www.elsevier.com/locate/chroma Steroid profiling in urine of intact glucuronidated and sulfated steroids using liquid chromatography-mass spectrometry ∗ Laurie De Wilde , Kris Roels, Pieter Van Renterghem, Peter Van Eenoo, Koen Deventer 1 Doping Control Laboratory (DoCoLab), Ghent University (UGent), Department Diagnostic Sciences, Technologiepark 30B, B-9052 Zwijnaarde, Belgium a r t i c l e i n f o a b s t r a c t Article history: Detection of endogenous anabolic androgenic steroids (EAAS) misuse is a major challenge in doping con- Received 26 November 2019 trol analysis. Currently, a number of endogenous steroids, which constitute the steroid profile, are quanti- Revised 6 May 2020 fied using gas chromatography (GC). With this methodology, only the sum of the free and glucuronidated Accepted 10 May 2020 steroids is measured together. A dilute-and-shoot LC-MS method, which is compliant with the quality Available online 23 May 2020 requirements for measuring EAAS established by the World Anti-Doping Agency (WADA), was devel- Keywords: oped and validated containing glucuronidated and sulfated steroids in order to gain some extra infor- Doping mation and to expand the existing steroid profile. The developed method is, to the best of our knowl- Urine edge, the first method to combine both steroid glucuronides and sulfates, which is compliant with the Steroid profile quality standards of the technical document on EAAS, established by WADA.
    [Show full text]
  • Characterization of the Inhibition of Genistein
    CHARACTERIZATION OF THE INHIBITION OF GENISTEIN GLUCURONIDATION BY BISPHENOL A IN HUMAN AND RAT LIVER MICROSOMES By JANIS LAURA COUGHLIN A thesis submitted to the Graduate School-New Brunswick Rutgers, The State University of New Jersey and The Graduate School of Biomedical Sciences University of Medicine and Dentistry of New Jersey in partial fulfillment of the requirements for the degree of Master of Science Joint Graduate Program in Toxicology written under the direction of Dr. Brian Buckley and approved by __________________________________ __________________________________ __________________________________ __________________________________ New Brunswick, New Jersey OCTOBER 2011 ABSTRACT OF THE THESIS Characterization of the Inhibition of Genistein Glucuronidation by Bisphenol A in Human and Rat Liver Microsomes By JANIS LAURA COUGHLIN Thesis Director: Dr. Brian Buckley Genistein is a natural phytoestrogen that is found abundantly in the soybean. Bisphenol A (BPA) is a synthetic chemical used in the synthesis of polycarbonate plastics and epoxy resins. Endocrine disrupting properties of both genistein and BPA have been well established by various laboratories. Because the adverse biological effects caused by genistein and BPA are similar, and may include common co-exposure scenarios in the general population such as in the consumption of a soy-milk latte from a polycarbonate plastic coffee mug, analysis of the perturbation of the metabolism via glucuronidation of genistein in the presence of BPA has been assessed. Human and rat liver microsomes were exposed to varying doses of genistein (0 to 250 μM) in the absence (0 μM) or presence (25 μM) of BPA. Treatment with 25 μM BPA caused non-competitive inhibition of the glucuronidation of genistein in human liver microsomes with a Ki value of 58.7 μM, represented by a decrease in Vmax from 0.93 ± 0.10 nmol/min/mg in the ii absence of BPA to 0.62 ± 0.05 nmol/min/mg in the presence of BPA, and a negligible change in Km values between treatment groups.
    [Show full text]
  • In Vitro Study of Flavonoids, Fatty Acids, and Steroids on Proliferation of Rat Hepatic Stellate Cells Farid A
    In vitro Study of Flavonoids, Fatty Acids, and Steroids on Proliferation of Rat Hepatic Stellate Cells Farid A. Badriaa,*, Abdel-Aziz A. Dawidarb, Wael E. Houssena, and Wayne T. Shierc a Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. E-mail: [email protected] b Chemistry Department, Faculty of Sciences, Mansoura University, Mansoura 35516 Egypt c Medicinal Chemistry Department, College of Pharmacy, University of Minnesota, Minne- apolis MN 55455 USA * Author for correspondence and reprint requests Z. Naturforsch. 60c, 139Ð142 (2005); received November 9/December 8, 2004 There is a wealth of evidence that hepatic stellate cells (HSCs) orchestrate most of the important events in liver fibrogenesis. After liver injury, HSCs become activated to a profi- brogenic myofibroblastic phenotype and can regulate net deposition of collagens and other matrix proteins in the liver. The proliferation of HSCs is mainly stimulated by the platelet- derived growth factor (PDGF). In this study, some compounds from natural resources have been tested for their activity to inhibit PDGF-driven proliferative activity of rat HSCs. Api- genin, quercetin, genistein, daidzin, and biochanin A exhibited > 75% inhibitory activity against HSC-T6. It was found that, γ-linolenic (γ-Ln), eicosapentanoic (EPA) and α- linolenic (α-Ln) acids showed a high inhibitory effect on proliferation of rat HSCs at 50 nmol/l. Cholest-4-ene-3,6-dione and stigmastone-4-en-3,6-dione are the most active steroids with in- hibitory activities > 80% and this is most likely due to the presence of the 4-en-3,6-dione moiety in both compounds.
    [Show full text]
  • Development and Application of Methods for Extraction and LC/MS/MS Analysis of Sex Steroids and Conjugates from Fish Feces
    Development and Application of Methods for Extraction and LC/MS/MS Analysis of Sex Steroids and Conjugates from Fish Feces By Lisa E. Peters A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Doctor of Philosophy Department of Environment and Geography University of Manitoba Winnipeg Copyright © 2014 Lisa E. Peters 1 Acknowledgments I would like to start by thanking my supervisor, Dr. Gregg Tomy, for his support, patience and resources during my Ph.D. program. He took a chance when I tried to convince him that my biology background would be a great addition to his chemistry lab. My husband, Vince Palace, and I also appreciated his support and genuine happiness for us when I announced we were expecting a baby in the middle of my studies. A sincere thanks also goes to my co-supervisor, Dr. Mark Hanson, for his support on so many levels (I wouldn’t even know where to start), and for doing his best to keep me on track, which was no small task. I would also like to thank my other thesis committee members, Drs. Gary Anderson and Feiyue Wang, for their encouragement and insightful comments. Gary gave a lot of extra time to review various thesis chapters and data, and to lend his expertise during the fish surgeries. I also had the pleasure of taking his Endocrinology course, which was probably the most informative and enjoyable class of my entire university student career. I would like to thank the technical staff and students from DFO, Suzanne Mittermuller, Kerry Wautier, Alea Goodmanson, Danielle Godard, Lisa Friedrich and Kirstin Dangerfield, and my lab mates Bruno Rosenberg, Kerri Pleskach, Colin Darling, Bonnie Gemmill and Lianna Bestvater for their technical input and help during my experiments.
    [Show full text]
  • Simultaneous Determination of Isoflavones, Saponins And
    September 2013 Regular Article Chem. Pharm. Bull. 61(9) 941–951 (2013) 941 Simultaneous Determination of Isoflavones, Saponins and Flavones in Flos Puerariae by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry Jing Lu,a Yuanyuan Xie,a Yao Tan, a Jialin Qu,a Hisashi Matsuda,b Masayuki Yoshikawa,b and Dan Yuan*,a a School of Traditional Chinese Medicine, Shenyang Pharmaceutical University; 103 Wenhua Rd., Shenyang 110016, P.R. China: and b Department of Pharmacognosy, Kyoto Pharmaceutical University; Shichono-cho, Misasagi, Yamashina-ku, Kyoto 607-8412, Japan. Received April 7, 2013; accepted June 6, 2013; advance publication released online June 12, 2013 An ultra performance liquid chromatography (UPLC) coupled with quadrupole time-of-flight mass spectrometry (QTOF/MS) method is established for the rapid analysis of isoflavones, saponins and flavones in 16 samples originated from the flowers of Pueraria lobata and P. thomsonii. A total of 25 isoflavones, 13 saponins and 3 flavones were identified by co-chromatography of sample extract with authentic standards and comparing the retention time, UV spectra, characteristic molecular ions and fragment ions with those of authentic standards, or tentatively identified by MS/MS determination along with Mass Fragment software. Moreover, the method was validated for the simultaneous quantification of 29 components. The samples from two Pueraria flowers significantly differed in the quality and quantity of isoflavones, saponins and flavones, which allows the possibility of showing their chemical distinctness, and may be useful in their standardiza- tion and quality control. Dataset obtained from UPLC-MS was processed with principal component analysis (PCA) and orthogonal partial least squared discriminant analysis (OPLS-DA) to holistically compare the dif- ference between both Pueraria flowers.
    [Show full text]
  • Endocrine-Immune-Paracrine Interactions in Prostate Cells As Targeted by Phytomedicines
    Published OnlineFirst January 13, 2009; DOI: 10.1158/1940-6207.CAPR-08-0062 Published Online First on January 13, 2009 as 10.1158/1940-6207.CAPR-08-0062 Cancer Prevention Research Endocrine-Immune-Paracrine Interactions in Prostate Cells as Targeted by Phytomedicines Nora E. Gray, Xunxian Liu, Renee Choi, Marc R. Blackman and Julia T. Arnold Abstract Dehydroepiandrosterone (DHEA) is used as a dietary supplement and can be metabolized to androgens and/or estrogens in the prostate. We investigated the hypothesis that DHEA metabolism may be increased in a reactive prostate stroma environment in the presence of proinflammatory cytokinessuchastransforminggrowth factor β1(TGFβ1), and further, whether red clover extract, which contains a variety of compounds including isoflavones, can reverse this effect. LAPC-4 prostate cancer cells were grown in coculture with prostate stromal cells (6S) and treated with DHEA +/− TGFβ1 or interleukin-6. Prostate-specific anti- gen (PSA) expression and testosterone secretion in LAPC-4/6S cocultures were compared with those in monocultured epithelial and stromal cells by real-time PCR and/or ELISA. Combined administration of TGFβ1 + DHEA to cocultures increased PSA protein secretion two to four times, and PSA gene expression up to 50-fold. DHEA + TGFβ1 also increased coculture production of testosterone over DHEA treatment alone. Red clover isoflavone treatment led to a dose-dependent decrease in PSA protein and gene expression and tes- tosterone metabolism induced by TGFβ1 + DHEA in prostate LAPC-4/6S cocultures. In this coculture model of endocrine-immune-paracrine interactionsin the prostate,TGF β1 greatly increased stromal-mediated DHEA effects on testosterone production and epithelial cell PSA production, whereas red clover isoflavones reversed these effects.
    [Show full text]
  • Androstenedione
    NTP TECHNICAL REPORT ON THE TOXICOLOGY ANd CARCINOGENESIS STUdIES OF ANdROSTENEdIONE (CAS NO. 63-05-8) IN F344/N RATS ANd B6C3F1 MICE (GAVAGE STUdIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 September 2010 NTP TR 560 NIH Publication No. 10-5901 National Institutes of Health Public Health Service U.S. dEPARTMENT OF HEALTH ANd HUMAN SERVICES FOREWORd The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Technical Report series began in 1976 with carcinogenesis studies conducted by the National Cancer Institute. In 1981, this bioassay program was transferred to the NTP. The studies described in the Technical Report series are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity and carcinogenicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure.
    [Show full text]
  • LGC Standards Pharmacopoeial Reference Standards 2014
    LL CTS INKSP RODUTO A L P ITH W WEBSHO LGC Standards Pharmacopoeial reference standards 2014 FOR STANDARDS WITH CofA SEE OUR CATALOGUE: PHARMACEUTICAL IMPURITIES AND PRIMARY REFERENCE STANDARDS LGC Quality – ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043 Pharmaceutical impurities Code Product CAS No. CS Price Unit Adiphenine Hydrochloride O LGC Standards N O MM1172.00 Adiphenine Hydrochloride 50-42-0 A 250mg HCl Pharmaceutical impurities and Adrenaline Tartrate OH H OH O OH primary reference standardsMM0614.00 2014 N OH Adrenaline Tartrate 51-42-3 A 500mg OH OH O OH OH H MM0614.02 L-Adrenaline 51-43-4 A 500mg OH N OH Imp. C (EP) as Hydrochloride: 1-(3,4-Di- O H OH MM0614.13 hydroxyphenyl)-2-(methylamino)ethanone 62-13-5 A 100mg N HCl Hydrochloride (Adrenalone Hydrochloride) OH (1R)-1-(3,4-Dihydroxyphenyl)-2- OH O S O MM0614.01 methylaminoethanesulphonic Acid H 78995-75-2 A 100mg OH N (Adrenaline -Sulphonate) OH Alanine NH2 MM0566.00 Alanine 56-41-7 A 500mg OH O Imp. A (Pharmeuropa): (2 S)-2-Aminobutanedioic Acid O NH 2 MM0567.00 OH (Aspartic Acid) 56-84-8 A 500mg OH O Albendazole O H MM0382.00 Albendazole N O 54965-21-8 A 500mg N H S N Imp. A (EP): 5-(Propylsulphanyl)-1H- H MM0382.01 N 80983-36-4 A 100mg NH2 benzimidazol-2-amine S N O H Imp. B (EP): Methyl [5-Propylsulphinyl)- N O MM0382.02 N 54029-12-8 A 100mg H 1H-benzimidazol-2-yl]carbamate S N O O H Imp.
    [Show full text]
  • Analysis of Anabolic Steroid Glucuronide and Sulfate Conjugates
    Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle Blokland, M.H.; Tricht, E.F. van; Ginkel L.A. van; Sterk, S.S. This is a "Post-Print" accepted manuscript, which has been published in “Catena” This version is distributed under a non-commencial no derivatives Creative Commons (CC-BY-NC-ND) user license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and not used for commercial purposes. Further, the restriction applies that if you remix, transform, or build upon the material, you may not distribute the modified material. Please cite this publication as follows: Blokland, M.H.; Tricht, E.F. van; Ginkel L.A. van; Sterk, S.S. (2017) Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle. The Journal of Steroid Biochemistry and Molecular Biology 174, p. 265-275 You can download the published version at: https://doi.org/10.1016/j.jsbmb.2017.10.007 Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle 5 M.H. Blokland*, E.F. van Tricht, L.A van Ginkel, S.S. Sterk RIKILT Wageningen University & Research, P.O. Box 230, Wageningen, The Netherlands 10 *Corresponding author: M.H. Blokland, Tel.: +31 317 480417, E-mail: [email protected] 15 Keywords: synthetic steroids, growth promoters, cattle, UHPLC-MS/MS, steroid profiling, steroidogenesis Abstract 20 A robust LC-MS/MS method was developed to quantify a large number of phase I and phase II steroids in urine.
    [Show full text]